Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
holding | ERAS | Common Stock | 10.8M | Jun 22, 2023 | See Footnotes | F1, F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ERAS | Stock Option (right to buy) | Award | $0 | +60K | $0.00 | 60K | Jun 22, 2023 | Common Stock | 60K | $2.66 | Direct | F4, F5 | |
holding | ERAS | Stock Option (right to buy) | 167K | Jun 22, 2023 | Common Stock | 167K | $5.81 | Direct | F3, F5 | |||||
holding | ERAS | Stock Option (right to buy) | 40K | Jun 22, 2023 | Common Stock | 40K | $5.35 | Direct | F5 |
Id | Content |
---|---|
F1 | Shares reported herein are held by Cormorant Global Healthcare Master Fund, LP (the "Master Fund"), Cormorant Private Healthcare Fund II, LP ("Fund II"), and a managed account (the "Account"). Cormorant Asset Management, LP ("Cormorant") serves as the investment manager of the Master Fund, Fund II, and the Account. Bihua Chen serves as manager of the general partner of Cormorant. Ms. Chen disclaims beneficial ownership of the shares reported herein except to the extent of her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that Ms. Chen is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose. |
F2 | Represents (i) 2,986,402 shares of Common Stock held by the Master Fund, (ii) 7,716,444 shares of Common Stock held by Fund II, and (iii) 110,400 shares of Common Stock held by the Account. |
F3 | Stock option grant for 166,666 shares, 41,667 shares of which become exercisable on 3/16/2022 and 124,999 shares of which become exercisable thereafter in equal monthly installments through 3/16/2025. |
F4 | 100% of the options to purchase shares vest on 6/22/2024, subject to the Reporting Person's continuous service to the Issuer on such vesting date. |
F5 | Stock options granted to Bihua Chen, in her capacity as a director of the Issuer. |